An Activist's Guide to the TB LAM Test

Treatment Action Group releases an updated version of its Activist’s Guide to the LAM Test with a complementary resource that tracks the status of LAM uptake in the 30 high TB/HIV burden countries.

Read More →

TB Valentine's Day Campaign

In anticipation of Valentine’s Day, the Stop TB Partnership launches an online campaign to celebrate love for all those affected by TB.

Read More →

Sanofi withdraws two patent applications on life-saving TB prevention drugs in Europe and in Indonesia

Activists urge Sanofi to do the same in other countries.

Read More →

MSF calls on Johnson & Johnson to lower price of lifesaving TB drug

Group protests at New York Stock Exchange as Johnson & Johnson releases earnings report.

Read More →

Lack of new antibiotics threatens global efforts to contain drug-resistant infections

Two new reports of the World Health Organization reveal a weak pipeline for antibiotic agents.

Read More →

Time to lower the price of Xpert cartridges to US$5

Advocates request Cepheid immediately reduce the price of Xpert tests to US$5, inclusive of service and maintenance; the company responds they are “not able to predict the amount of further reductions or when they may be available”; advocates reiterate the request that Cepheid provide a detailed plan for how it will lower the price of Xpert tests to US$5.

Read More →

TB Alliance responds to questions raised by activists in relation to pretomanid

MSF, TAG and TB CAB raised a number of outstanding medical and research questions regarding pretomanid and the regimen BPaL.

Read More →

WHO announces changes to the treatment of drug-resistant TB

WHO releases a Rapid Communication in advance of the updated guidelines for the treatment of drug-resistant TB expected in 2020.

Read More →

New TAG report: Funding for TB research climbed to new high in 2018

The report — Tuberculosis Research Funding Trends, 2005–2018 — presents new data on funding for TB research and development in 2018 and analyzes trends in spending since 2005.

Read More →

Stop TB Partnership launches the updated Global Plan to End TB 2018-2022

The updated Global Plan calls for 2.6 billion USD per year for vital research and development of new TB diagnostic tools, new drug regimens and a new vaccine, and 13 billion USD per year for TB care and prevention.

Read More →

Page 1 of 103 · Total posts: 10

1 2 Last→